Dr. Karthik Mikkineni
MD, FACS, FSVS, RPVI
A Visionary Leader in Vascular &
Endovascular Surgery
Dr. Karthik Mikkineni is an internationally recognized vascular and endovascular surgeon, known for his pioneering work in complex aortic interventions, limb salvage, and carotid disease management. As the Chief of Vascular and Endovascular Surgery at the Oklahoma City VA Health Care System, he has led transformative advancements in patient care, surgical innovation, and physician training. Now, he brings his unparalleled expertise to India as the founding director of RIVEA Vascular Institute—a premier center for cutting-edge vascular and interventional radiology care in Hyderabad.
Dr. Karthik Mikkineni
MD, FACS, FSVS, RPVI
Dr. Mikkineni’s career has been shaped by a relentless pursuit of excellence. A former Assistant Professor of Surgery at Stanford University School of Medicine, he played a pivotal role in establishing Stanford’s Community Academic Practice (CAP) and Advanced Aortic Center. His leadership expanded access to advanced vascular care and set new benchmarks in outpatient surgery, hybrid ORs, and interventional excellence. Recognized as a Distinguished Faculty Member at Stanford, he led national training programs, secured NIH and AHA research grants, and contributed to groundbreaking developments in aortic aneurysm management.
Dr. Mikkineni completed his Integrated Vascular Surgery Residency at Allegheny General Hospital, Temple & Drexel College of Medicine, under the 0+5 track, a highly specialized pathway focusing solely on vascular and endovascular surgery. He remains the only Indian graduate of this competitive training program. His training also includes an internship at NewYork-Presbyterian/Weill Cornell Medical College.
A Fellow of the American College of Surgeons (FACS) and the Society for Vascular Surgery (FSVS), he is among an elite group of vascular specialists worldwide, with research that has influenced global treatment guidelines. His research on aortic aneurysm biomechanics and rupture prediction models has received international acclaim, influencing clinical guidelines and surgical best practices.
At RIVEA Vascular Institute, Dr. Mikkineni’s vision is clear: to redefine vascular care in India, merging minimally invasive endovascular treatments with the highest level of open surgical expertise. Under his leadership, RIVEA will be the first in India to introduce Transcarotid Artery Revascularization (TCAR), alongside advanced fenestrated and branched aortic endografts (FEVAR, EVAR, TEVAR). His commitment extends beyond surgery—to mentorship, research, and building a sustainable model for world-class vascular care in India.